Thomas Hughes

Thomas Hughes

Baker & McKenzie LLP


Thomas Hughes is a partner in Baker McKenzie's Chicago office and a member of the Corporate & Securities Practice Group. Tom represents corporate, private equity and hedge fund clients in domestic and international M&A, joint venture, licensing and other significant transactions. Tom's industry experience includes clients in the healthcare and pharmaceuticals, food and beverage, industrials, gaming and hospitality, technology, insurance and financial services sectors.

Practice Focus

Tom focuses his practice on mergers and acquisitions, complex transactions and corporate law. He also advises clients on governance and general corporate matters, including compliance with applicable laws and regulations of governmental authorities, regulatory bodies and stock exchanges, as well as activist-related matters.

Representative Legal Matters

  • Advised H. Lundbeck A/S in the acquisition of Alder BioPharmaceuticals, Inc, a company committed to migraine treatment and prevention, a transaction valued at USD 1.95 billion.

  • Advised Servier Pharmaceuticals LLC, an independent international French-based pharmaceutical company, in its acquisition of the Oncology business of Shire (now part of Takeda), a leading global biotechnology company focused on rare diseases, a transaction valued at USD 2.4 billion.

  • Advised Mondel─ôz Global LLC in its acquisition of Perfect Snacks LLC, a maker of refrigerated nutrition bars.

  • Advised LVMH Moët Hennessy Louis Vuitton SE in its acquisition of Belmond Ltd., owners, part-owners or managers of 45 luxury hotel, restaurant, train and river cruise properties, a $3.2 billion enterprise value transaction.

  • Advised Gebr. Knauf KG, a German-based manufacturer of building materials operating more than 220 factories worldwide, in its proxy contest and subsequent acquisition of USG Corporation, a Chicago-headquartered industry-leading manufacturer of building products and innovative solutions, a $7 billion enterprise value transaction.

  • Advised CRIF S.p.A. on the sale of its Lending Solutions Divisions to Thoma Bravo LLC.

  • Advised Abbott Laboratories in connection with the sale of a business in Argentina.

Prior to joining the Firm, Tom advised:

  • Amadeus IT Holding SA in its acquisition of Navitaire LLC, a wholly owned subsidiary of Accenture that provides technology and business services to the airline industry, for USD 830 million.

  • Becton, Dickenson & Company in its acquisition of CareFusion Corporation in a merger transaction valued at USD 12.2 billion.

  • Compuware Corporation in an unsolicited bid from Elliott Management Corporation, and its USD 2.5 billion acquisition by private equity investment firm Thoma Bravo, LLC.

  • Goldman, Sachs & Co. as financial advisor to Cardinal Health, Inc. in its acquisition of the Cordis business from Johnson & Johnson for an aggregate value of USD 1.99 billion.


  • Illinois~United States (2016)
  • New York~United States (2005)


  • University of Michigan Law School (J.D., cum laude) (2004)
  • University of Michigan (M.S.E.) (1999)
  • University of Michigan (B.S.E. Industrial and Operational Engineering, magna cum laude) (1998)

Contributing Editor, Michigan Law Review, 2004